Effects of avitinib on the pharmacokinetics of osimertinib in vitro and in vivo in rats

BACKGROUND: Avitinib is one type of the third‐generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of non‐small cell lung cancer (NSCLC) with EGFR mutations. The purpose of this study was to investigate the effect of avitinib on the pharmacokinetics...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Wu, Qingjun, Jiang, Hui, Wang, Shuanghu, Dai, Dapeng, Chen, Feifei, Meng, Deru, Geng, Peiwu, Tong, Hongfeng, Zhou, Yunfang, Pan, Debiao, Zhou, Quan, Wang, Chunjie
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529555/
https://ncbi.nlm.nih.gov/pubmed/32812378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13587
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars